Clinical Trials Directory

Trials / Unknown

UnknownNCT03239652

Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia

Safety and Efficacy of Prostatic Artery Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
National Cheng-Kung University Hospital · Academic / Other
Sex
Male
Age
50 Years
Healthy volunteers
Not accepted

Summary

In this proposal, the investigators plan to conduct a clinical trial to validate the efficacy and safety of microspheres (T-ACE Beads).

Detailed description

T-ACE Beads can be used for prostatic arterial embolization safely and efficiently. Furthermore, investigator's microspheres has advantageous characteristics in biodegradability, drug delivery capability, and cost-effectiveness. After the clinical trial, we anticipate introducing a new microsphere for Lower Urinary Tract Symptom/Benign prostatic hyperplasia patients, which is beneficial to the participants in precise medicine as well as in the pharmaceutical and medical device industry.

Conditions

Interventions

TypeNameDescription
DEVICETaiwan ACE BeadsSimilar with conventional Transcatheter Arterial chemo-embolization, radiologist use Taiwan ACE Beads instead of Gelfoam or polyvinyl alcohol.

Timeline

Start date
2017-01-01
Primary completion
2020-06-30
Completion
2020-06-30
First posted
2017-08-04
Last updated
2019-10-17

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT03239652. Inclusion in this directory is not an endorsement.